Please Wait...

Upcoming Cardiac Safety Webinar Series

Join Bioclinica's Cardiovascular Safety experts this October for a 3-part webinar series as they review recent advancements and direction in the evaluation of cardiac safety and efficacy in drug development. Through use of case studies, presenters will share insights focused on the recent ICH E14 Q&A, application of cardiovascular imaging in drug safety monitoring and electronic clinical event adjudication.

Attend one or more of the webinars in this series for a critical review of recent trends in cardiovascular imaging, perspective on use of QT prolongation as a cardiac safety endpoint, and to better understand efficiencies gained through centralized adjudication of clinical outcomes.

Each webinar is designed to be 1-hour long, educational and interactive.

Upcoming cardiac safety webinar dates and times:

October 16, 2017 - 11:00am (Eastern)

Cardiovascular Safety in Biopharmaceutical Product Development – From QT Prolongation and Beyond

The cardiac safety ECG environment continues to mature and expand based on scientific advancements and understanding of pathways and systems associated with generating cardiac risk. The most recent ICH E14 Q&A, and the ensuing cardiac safety conferences and industry meetings, have highlighted the advancements and direction for evaluating the cardiac safety during the drug development process. In addition to the role of ECG data in cardiac safety assessment, there are also considerations related to the "off-target" blood pressure safety signals, which are a consideration from a safety and regulatory perspective.

October 19, 2017 - 10:00am (Eastern)

Cardiovascular Imaging for Monitoring Safety: Visualizing Outcomes

It is paramount that new medical therapies be shown to be safe for patients. Monitoring safety is accomplished in a variety of ways depending on the therapy and its potential adverse impact. There are many therapies that have been shown to have adverse cardiovascular implications and fortunately, innovative tests and tools are available that are effective in monitoring the safety of new biologics, drugs and devices in development. The goal of this webinar is to discuss the application of cardiovascular imaging when monitoring safety in the development of new medical therapies.

October 26, 2017 - 10:00am (Eastern)

Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution

New drugs, biologics and devices in development today can be very effective at treating the targeted disease or condition. However, many may also have a negative impact on cardiovascular outcomes and therefore the review of clinical events need to be considered. This webinar will provide an overview of the centralized review of cardiovascular safety through implementation of a Clinical Events Committee (CEC) and the importance of collecting and adjudicating events and providing unbiased assessments through electronic expert evaluation. This presentation will highlight the role electronic expert evaluation plays in improving the quality of endpoint assessments for cardiovascular outcomes. A detailed discussion on the Clinical Event adjudication process workflow will be shared.

Learn more and register for one or all of these webinars today!

Cardiovascular Safety Insights Webinar Series

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Visit us at @DrugInfoAssn's DIA China to learn how Bioclinica's science & technology expertise can advance the deve… https://t.co/r4822CjVvv
Bioclinica (12 hours ago)
Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (3 days ago)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (4 days ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (5 days ago)
Greetings from Milan! Bioclinica looks forward to connecting with our #pharma and #CRO friends at #octEurope! Raggy… https://t.co/KqG99HqDWA
Bioclinica (6 days ago)
Could EDC software be a game changer in your clinical trial? Here's what to look for in evaluating different syste… https://t.co/MyxooYMwqk
Bioclinica (6 days ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box